Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

Objectives: The purpose of this study was to compare the safety and efficacy of
acetylsalicylic acid (ASA) and warfarin for thromboprophylaxis after the Fontan procedure …

This chapter about antithrombotic therapy in neonates and children is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Among children, newborn infants are most vulnerable to development of thrombosis and
serious thromboembolic complications. Amongst newborns, those neonates who are …

Since the Sixth American College of Chest Physicians Consensus Conference on
Antithrombotic Therapy, the results of clinical trials have provided important new information …

Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

Alan D. Michelson, MD; Edward Bovill, MD; and Maureen Andrew, MD, Chair, tntithrombotic
therapy is required for the prevention and. 1" 1 treatment of thromboembolic complications in …

A ntithrombotic therapy is required for the~ re: enti~ n and treatment of thromboembolic
complications m specific pediatric patient populations. Recommendations for antithrombotic …

As thromboembolic events (TEE) are common in adults with congenital heart disease
(ACHD), adequate oral anticoagulation for prophylaxis or treatment of TEE is important. Until …

Objectives: The study sought to identify factors associated with increased risk of thrombosis
after Fontan. Background: The Fontan procedure is the culmination of staged palliation for …